摘要
心肌病具有高度的复杂性和异质性,对它的认识和研究已从形态学逐渐过渡到分子生物学和遗传学,揭示了遗传致病基因、基因缺失和基因突变是一些家族性和非家族性心肌病的直接病因,并与临床表型密切相关,为现在和未来的基因靶向治疗提供了可靠依据。
Due to the high level of complexity and heterogeneity in cardiomyopathy,it has been a gradual transition of research from morphology to molecular biology and genetics.Pathogenesis such as genetic pathogenic gene,gene deletion and gene mutation,has been revealed as direct etiology of certain familial and non-familial cardiomyopathy,which are also closely related with clinical phenotype.Undoubtedly,it provides the reliable evidence to targeted therapy nowadays as well as in the future.
作者
张昕彤
任卫东
ZHANG Xintong;REN Weidong(Department of Ultrasound,Shengjing Hospital of China Medical University,Shenyang 110000,Liaoning,China)
出处
《心血管病学进展》
CAS
2024年第11期961-963,共3页
Advances in Cardiovascular Diseases
关键词
心肌病
基因突变
基因治疗
Cardiomyopathy
Gene mutation
Gene therapy